The burgeoning landscape of emerging treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a alike https://idaqcyd425703.wikijm.com/1962003/retatrutide_vs_tirzepatide_a_comparative_analysis